Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck

Oral Oncol. 2004 Jan;40(1):28-35. doi: 10.1016/s1368-8375(03)00129-5.

Abstract

Tumors show an increased glucose uptake that is mediated by glucose transport proteins. We have analyzed the expression of the sodium-dependent glucose co-transporters SGLT-1 and-2 in short-term cultures of squamous cell carcinomas of the head and neck (HNSCC) by RT-PCR. Distribution of the SGLT-1 protein in HNSCC tissues was investigated by immunohistochemistry. While we observed in 17/36 HNSCC short-term cultures the SGLT-1 mRNA, we found no SGLT-2 expression. SGLT-1 mRNA expression occurred preferentially in cultures originating from moderately and well differentiated HNSCC. In tumor tissues a heterogeneous SGLT-1 staining restricted to differentiated tumor cells was seen in 27/30 HNSCC analyzed. In normal mucosa SGLT-1 staining was also confined to differentiated compartments and lacked in dysplastic areas. Our data indicate a differentiation-dependent expression of SGLT-1 in HNSCC. This is important knowledge for the planning of glucose-targeting therapies and suggest SGLT-1 as a differentiation marker in head and neck tissues.

MeSH terms

  • Blotting, Western
  • Carcinoma, Squamous Cell / metabolism*
  • Cell Line, Tumor
  • HT29 Cells
  • Head and Neck Neoplasms / metabolism*
  • Humans
  • Immunohistochemistry
  • Membrane Glycoproteins / metabolism*
  • Monosaccharide Transport Proteins / metabolism*
  • Precancerous Conditions / metabolism*
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Sodium-Glucose Transporter 1

Substances

  • Membrane Glycoproteins
  • Monosaccharide Transport Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • SLC5A1 protein, human
  • Sodium-Glucose Transporter 1